5 / 266
5
2014 Registration Document
Presentation of the Group
1
Consolidated key figures
2014 consolidated key figures
The key figures for 2014 provided below have been audited by the Group’s Statutory Auditors.
The 2012 comparative information provided below (“2012 restated”) has been restated in 2013 to reflect the classification of discontinued operations
in accordance with IFRS 5 (reorganisation of the Group’s activities in Turkey and India), as well as retrospective application of the revised IAS 19
standard on Employee Benefits.
(in € million)
2014
2013
2012 restated 2012 published
Selected financial information from the consolidated income statement
Net sales
74,706
74,888
75,673
76,789
Recurring operating income
before depreciation and amortisation
3,768
3,669
3,642
3,688
Recurring operating income
2,387
2,238
2,124
2,140
Recurring operating income
including income from associates and joint ventures
2,423
2,267
2,196
2,212
EBIT
2,572
2,412*
1,537*
1,506*
Net income from continuing operations
1,300
1,058
273
235
Net income from continuing operations – Group share
1,182
949
150
113
Net income
1,367
1,364
1,342
1,316
Net income – Group share
1,249
1,263
1,259
1,233
Selected financial information from the consolidated cash flow statement
Cash flow from operations
2,504
2,039
2,708**
2,228**
Net cash from operating activities
2,609
1,675
2,459
1,973
Net cash from (used in) investing activities
(3,397)
(855)
337
337
Net cash from (used in) financing activities
(874)
(2,489)
60
546
Net change in cash and cash equivalents
(1,643)
(1,816)
2,724
2,724
Selected financial information from the consolidated statement of financial position
Net debt
4,954
4,117
4,320
4,320
Shareholders’ equity
10,228
8,679***
8,047
8,361
Shareholders’ equity - Group share
9,191
7,925***
7,181
7,487
* Restated due to the reclassification of the income from associates and joint ventures.
** Restated due to the reclassification of borrowing cost to financing activities.
*** Restated from premature application of IFRIC 21 interpretation.
These restatements are described in note 4 of the consolidated financial statements.